Learn More
Invitrogen™ Human INMT (aa 137-187) Control Fragment Recombinant Protein
Recombinant Protein
Marca: Invitrogen™ RP107054
Descripción
Highest antigen sequence indentity to the following orthologs: Mouse (67%), Rat (67%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-66379 (PA5-66379. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
N-methylation of endogenous and xenobiotic compounds is a major method by which they are degraded. This gene encodes an enzyme that N-methylates indoles such as tryptamine.
Especificaciones
O95050 | |
Blocking Assay, Control | |
11185 | |
100 μL | |
Amine N-methyltransferase; aromatic alkylamine N-methyltransferase; arylamine N-methyltransferase; indolamine N-methyltransferase; Indolethylamine N-methyltransferase; Inmt; nicotine N-methyltransferase; Temt; Thioether S-methyltransferase | |
INMT | |
Human | |
His-ABP-tag | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
≥5.0 mg/mL | |
1 M urea, PBS with no preservative; pH 7.4 | |
Human INMT (aa 137-187) Control Fragment | |
RUO | |
INMT | |
Unconjugated | |
Recombinant | |
RVLKCDVHLGNPLAPAVLPLADCVLTLLAMECACCSLDAYRAALCNLASLL | |
E. coli | |
>80% by SDS-PAGE and Coomassie blue staining |
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.